South America DNA Synthesis Market Overview
As per MRFR analysis, the South America DNA Synthesis Market Size was estimated at 212 (USD Million) in 2023. The South America DNA Synthesis Market Industry is expected to grow from 250(USD Million) in 2024 to 750 (USD Million) by 2035. The South America DNA Synthesis Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035)
Key South America DNA Synthesis Market Trends Highlighted
In the South America DNA synthesis market, several key trends are emerging that reflect the growing importance of genetic research and biotechnology in the region. One of the principal market drivers is the rising demand for personalized medicine, which necessitates advancements in genetic research and synthesis technologies. Governments in South America are increasingly investing in biotechnology initiatives to enhance healthcare outcomes, thus propelling the DNA synthesis market forward.Â
Additionally, the ongoing collaboration between academic institutions and industry players is fostering innovation, leading to the development of more efficient synthesis processes and applications.There are significant opportunities to be explored in the agricultural sector, where genetically modified organisms (GMOs) and synthetic biology can enhance crop resilience and yield. South America, being a major agricultural producer, can benefit from these advancements, addressing food security and sustainability challenges.Â
Moreover, the rise of biotechnology startups across countries like Brazil and Argentina is creating a dynamic environment that encourages the exploration of novel genetic solutions in medicine and agriculture. Recently, the region has also seen a surge in investments aimed at improving laboratory infrastructure and capabilities for DNA synthesis.This includes creating more accessible and cost-effective solutions, which aligns with the trend of democratizing biotechnological advancements across South America.Â
Educational programs focusing on genomics and molecular biology are also on the rise, nurturing a skilled workforce that can drive further growth in the market. Overall, the South America DNA synthesis market is characterized by a focus on innovation, collaboration, and addressing pressing regional challenges through biotechnology.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South America DNA Synthesis Market Drivers
Increasing Investments in Biotechnology Research and Development
The South America DNA synthesis market is expanding significantly as a result of rising investments in biotechnology R&D. Recognizing biotechnology's promise, governments and corporate institutions are setting aside funds to encourage innovation. For example, several advancements in DNA synthesis methods have been made possible by the approximately $10 million USD that Brazil's National Science and Technology Fund allocates each year to biotechnology initiatives. As local businesses develop in DNA synthesis techniques, this dedication to improving biotech skills is expected to strengthen the market's position in the area, making it a crucial industry in South America.
veRising Demand for Personalized Medicine
The rise in personalized medicine is another key driver for the South America DNA Synthesis Market Industry. Personalized medicine relies heavily on genetic information to tailor treatments to individual patients, which in turn increases the need for advanced DNA synthesis technologies.Â
A recent report indicated that over 25% of South American patients are benefiting from targeted therapies that require bespoke genetic profiles. Organizations such as the Brazilian Society of Clinical Oncology are actively promoting personalized treatment approaches, which is directly driving demand for DNA synthesis services and products in the region.
Growth in Genomic Research Initiatives
The South America DNA Synthesis Market Industry is benefiting from a steady growth in genomic research initiatives. Countries like Brazil and Argentina are enhancing their genomic research capabilities with the establishment of various biobanks and genetic databases.Â
Notably, the Brazilian Institute of Genome and Biotechnology announced a partnership for a multi-million-dollar initiative aimed at mapping the genetic diversity of plant species. This investment not only strengthens research capacity but also raises the demand for DNA synthesis technologies essential for genomic studies, making it a vital growth driver in South America.
Increased Applications in Synthetic Biology
The South America DNA Synthesis Market Industry is experiencing growth due to the expanded applications of synthetic biology across various sectors, including agriculture and pharmaceuticals. Companies in Argentina and Chile are actively developing genetically modified organisms to enhance crop resistance and yield.Â
For example, the National Agricultural Technology Institute of Argentina has reported an increase in the use of synthetic biology to develop crops with improved traits.This trend is enhancing demand for DNA synthesis tools and services, solidifying the role of synthetic biology in fostering innovation within the South American DNA Synthesis Market Industry.
South America DNA Synthesis Market Segment Insights
DNA Synthesis Market Application Insights
The South America DNA Synthesis Market, particularly in the Application segment, is experiencing significant growth fueled by advancements across various fields such as Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development. Gene Therapy plays a crucial role in treating genetic disorders, driving demand for sophisticated DNA synthesis techniques that aim to enhance precision in treatment. This Application remains a major focus due to its potential for groundbreaking therapies, addressing unmet medical needs in the region.
Synthetic Biology, another vital area within the Application segment, revolutionizes the way organisms are engineered, presenting vast opportunities for innovations in agriculture and biofuels that are highly relevant to South America's rich biodiversity. Moreover, Molecular Diagnostics stands out as a critical tool for disease detection and monitoring, particularly in the wake of increased health concerns, allowing for timely intervention and personalized medicine strategies.Â
It is significant that this application leverages cutting-edge DNA synthesis technology to enhance diagnostic accuracy and speed.Lastly, Vaccine Development has received considerable attention, especially following the global health crises that highlighted the urgency for rapid and effective vaccine solutions. The ongoing investments in vaccine research and the development of new platforms signify the importance of this Application, emphasizing a united effort to improve public health and preparedness in South America.Â
Collectively, these segments underscore a favorable environment for technological advancements and healthcare enhancements driven by the South America DNA Synthesis Market, signaling robust growth opportunities supported by regional biodiversity and an expanding scientific community.As these applications evolve, they not only contribute significantly to the South American economy but also highlight the region's commitment to innovation and healthcare improvement.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
DNA Synthesis Market Product Type Insights
The South America DNA Synthesis Market demonstrates a diverse range of Product Types, prominently featuring Oligonucleotides, Gene Fragments, and Gene Libraries. Oligonucleotides are critical in various applications, including Research and Development, diagnostics, and therapeutic strategies, thereby contributing to remarkable growth in the biotechnology sector. Gene Fragments play a significant role as building blocks in genetic research, facilitating advancements in synthetic biology and personalized medicine.Â
Meanwhile, Gene Libraries serve as valuable resources for researchers, enabling comprehensive genetic exploration and increasing the efficiency of gene discovery processes.The rising demand for precision medicine and next-generation sequencing technologies underscores the importance of these product types. In South America, the increasing emphasis on genomic research, coupled with advancements in biotechnology, establishes a dynamic environment where these product types can thrive.Â
This market is further supported by favorable government initiatives aimed at enhancing research capabilities and fostering innovation in the life sciences industry, creating promising opportunities for growth and collaboration.
DNA Synthesis Market End User Insights
The End User segment of the South America DNA Synthesis Market comprises Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Academic Research Institutions are crucial in driving innovation and discovery, playing a pivotal role in advancing genetic research and education. Pharmaceutical Companies leverage DNA synthesis for drug development and personalized medicine, significantly enhancing therapeutic options and improving patient outcomes. Biotechnology Companies utilize DNA synthesis to create novel products and solutions that cater to various industries, emphasizing the importance of synthetic biology in addressing global challenges.
Clinical Laboratories rely on advanced DNA synthesis techniques for diagnostic testing and genomic analysis, ensuring high accuracy in medical assessments. These sectors collectively contribute to the market's expansion, driven by increasing demand for genetic research, advancements in therapeutics, and rising investments in biotechnology. The growing focus on Research and Development in South America, supported by government initiatives and funding, further strengthens the potential of these end users, making them fundamental to the overall growth and evolution of the South America DNA Synthesis Market.
DNA Synthesis Market Technology Insights
The South America DNA Synthesis Market is experiencing significant developments in the Technology segment, which encompasses various synthesis methods essential for genetic engineering and molecular biology applications. Within this framework, Solid-Phase Synthesis is notable for its efficiency in constructing oligonucleotides, making it a preferred choice for numerous researchers focused on high-throughput applications. Liquid-Phase Synthesis, while less common, finds its relevance in specific applications where flexibility and adaptability are required.Furthermore, PCR-Based Synthesis is a pivotal technique widely used in diagnostics and research, allowing for the amplification of specific DNA sequences.Â
As the demand for personalized medicine and genetic testing rises in South America, these methods are becoming increasingly important. The insights from South America DNA Synthesis Market data indicate substantial growth driven by advancements in technology, a surge in Research and Development activities, and rising investments in pharmaceutical and biotechnology industries. Overall, the blending of these technologies is crucial for the market's dynamics, providing essential tools for innovation and research across various sectors in the region.
South America DNA Synthesis Market Key Players and Competitive Insights
The competitive landscape of the South America DNA Synthesis Market is characterized by a dynamic interplay of various players striving to capitalize on the growing demand for synthetic DNA across multiple applications such as biotechnology, pharmaceuticals, and agriculture. As research and development activities expand across universities and private research institutions, the market has seen an increase in investment, which, in turn, has fostered innovation and product development. Key players are focusing on enhancing their service offerings to address the specific needs of the regional market, including the affordability and accessibility of DNA synthesis technologies.Â
The landscape is also shaped by collaborations, partnerships, and investment in infrastructure that aims to support scientific advancements and meet the unique challenges within the South American context.Agilent Technologies has established a strong foothold in the South America DNA Synthesis Market through its innovative offerings and extensive expertise in biotechnology. The company is recognized for its advanced technologies that facilitate efficient DNA synthesis processes, which are crucial for various applications in research laboratories and industrial setups across the region.Â
Agilent Technologies leverages its robust distribution network and sales force to maintain a significant presence in key markets such as Brazil and Argentina. Its strengths lie in the reliability of its products, coupled with strong customer support and a commitment to quality, which have cemented its reputation as a leading provider in DNA synthesis solutions within South America. This operational efficiency enables Agilent Technologies to adapt swiftly to market demands and maintain a competitive edge.Thermo Fisher Scientific is another major player in the South America DNA Synthesis Market, renowned for its comprehensive portfolio of products and services that cater to a range of scientific needs.Â
The company offers a variety of synthesis solutions, including oligonucleotides and gene constructs that are essential for genetic research and development. With a strong market presence, Thermo Fisher Scientific focuses on enhancing its service capabilities and expanding its product lines to meet the specific demands of South American researchers and institutions. Key strengths of the company include its technological advancements, which ensure high-quality synthesis, and its commitment to customer service, making it a preferred choice among scientists.Â
Thermo Fisher Scientific has also engaged in strategic mergers and acquisitions aimed at bolstering its market position and enhancing its research capabilities in the region, thus ensuring a sustained competitive advantage in the rapidly evolving DNA synthesis landscape.
Key Companies in the South America DNA Synthesis Market Include
- Integrated DNA Technologies
South America DNA Synthesis Market Industry Developments
The South America DNA Synthesis Market has seen notable developments recently, particularly with companies like Agilent Technologies and Thermo Fisher Scientific expanding their operational capabilities in the region. In September 2023, Twist Bioscience announced a significant investment in enhancing its manufacturing facility in Brazil, aimed at increasing its production capacity for synthetic DNA, thus catering to the growing demand in the biotechnology sector. Alongside this, Qiagen and Genomatica have been collaborating on projects focused on sustainable DNA synthesis processes, reflecting the increasing importance of environmental considerations in biotechnology.Â
Furthermore, in August 2023, Bioneer was reported to have secured a strategic partnership with local universities to foster Research and Development initiatives, enhancing local talent and innovation. In terms of mergers and acquisitions, ThermoGenesis Holdings was noted to have completed an acquisition of a Brazilian biotechnology firm in July 2023, aligning with their strategy to strengthen their presence in the South American DNA synthesis landscape. The overall market valuation is expected to increase significantly due to these developments, contributing to regional advancements and the rapid growth of synthetic biology applications across various sectors, including healthcare and agriculture.
South America DNA Synthesis Market Segmentation Insights
-
DNA Synthesis Market Application Outlook
-
DNA Synthesis Market Product Type Outlook
-
DNA Synthesis Market End User Outlook
- Academic Research Institutions
-
DNA Synthesis Market Technology Outlook
-
DNA Synthesis Market Regional Outlook
Report Attribute/Metric
|
Details
|
Market Size 2023
|
212.0(USD Million)
|
Market Size 2024
|
250.0(USD Million)
|
Market Size 2035
|
750.0(USD Million)
|
Compound Annual Growth Rate (CAGR)
|
10.503% (2025 - 2035)
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
Base Year
|
2024
|
Market Forecast Period
|
2025 - 2035
|
Historical Data
|
2019 - 2024
|
Market Forecast Units
|
USD Million
|
Key Companies Profiled
|
Agilent Technologies, Thermo Fisher Scientific, Genomatica, DNA2.0, Synlogic, Bioneer, Qiagen, Twist Bioscience, Illumina, Eurofins Scientific, GeneScript, ThermoGenesis Holdings, Biomatik, Integrated DNA Technologies, Macrogen
|
Segments Covered
|
Application, Product Type, End User, Technology, Regional
|
Key Market Opportunities
|
Growing biotech research sectors, increasing demand for synthetic biology, Expanding pharmaceuticals and diagnostics, Government funding and initiatives, Rising personalized medicine applications
|
Key Market Dynamics
|
Rising biotech research activities, Increasing genomic research funding, Growing demand for synthetic biology, Expanding applications in healthcare, and Advancements in gene editing technologies
|
Countries Covered
|
Brazil, Mexico, Argentina, Rest of South America
|
Frequently Asked Questions (FAQ) :
The South America DNA Synthesis Market is expected to be valued at 250.0 USD Million in 2024 and projected to reach 750.0 USD Million by 2035.
The expected CAGR for the South America DNA Synthesis Market from 2025 to 2035 is 10.503%.
In 2024, Molecular Diagnostics is the leading application, valued at 80.0 USD Million in the South America DNA Synthesis Market.
By 2035, the market value for Gene Therapy in the South America DNA Synthesis Market is expected to reach 180.0 USD Million.
Brazil holds the largest market share in the South America DNA Synthesis Market, valued at 100.0 USD Million in 2024.
By 2035, the South America DNA Synthesis Market in Argentina is projected to be valued at 120.0 USD Million.
Major players in the South America DNA Synthesis Market include Agilent Technologies, Thermo Fisher Scientific, and Illumina.
The Synthetic Biology application is expected to grow from 70.0 USD Million in 2024 to 210.0 USD Million by 2035.
The anticipated market value for Vaccine Development in the South America DNA Synthesis Market by 2035 is 120.0 USD Million.
The South America DNA Synthesis Market in Mexico is expected to grow from 60.0 USD Million in 2024 to 180.0 USD Million by 2035.